BC Week In Review | Dec 9, 2013
Clinical News

CMC-001 regulatory update

CMC Contrast said FDA granted Orphan Drug designation for CMC-001 for use as a targeted contrast agent for diagnostic MRI to detect and localize focal liver lesions in patients where gadolinium-based contrast agents are contraindicated...
Items per page:
1 - 1 of 1